- Home
- SVRE vs XXII Comparison
SVRE vs XXII Comparison
Compare SVRE & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRE
- XXII
- Stock Information
- Founded
- SVRE 2014
- XXII 1998
- Country
- SVRE Israel
- XXII United States
- Employees
- SVRE N/A
- XXII N/A
- Industry
- SVRE
- XXII Medicinal Chemicals and Botanical Products
- Sector
- SVRE
- XXII Health Care
- Exchange
- SVRE Nasdaq
- XXII Nasdaq
- Market Cap
- SVRE 2.8M
- XXII 2.8M
- IPO Year
- SVRE 2022
- XXII N/A
- Fundamental
- Price
- SVRE $0.88
- XXII $5.10
- Analyst Decision
- SVRE
- XXII
- Analyst Count
- SVRE 0
- XXII 0
- Target Price
- SVRE N/A
- XXII N/A
- AVG Volume (30 Days)
- SVRE 644.4K
- XXII 2.5M
- Earning Date
- SVRE 08-27-2024
- XXII 11-12-2024
- Dividend Yield
- SVRE N/A
- XXII N/A
- EPS Growth
- SVRE N/A
- XXII N/A
- EPS
- SVRE N/A
- XXII N/A
- Revenue
- SVRE $458,952.00
- XXII $17,304,000.00
- Revenue This Year
- SVRE N/A
- XXII $56.94
- Revenue Next Year
- SVRE $422.52
- XXII $2.98
- P/E Ratio
- SVRE N/A
- XXII N/A
- Revenue Growth
- SVRE N/A
- XXII N/A
- 52 Week Low
- SVRE $0.80
- XXII $3.90
- 52 Week High
- SVRE $27.00
- XXII $581.85
- Technical
- Relative Strength Index (RSI)
- SVRE 42.74
- XXII 41.23
- Support Level
- SVRE $0.80
- XXII $4.80
- Resistance Level
- SVRE $0.94
- XXII $12.49
- Average True Range (ATR)
- SVRE 0.10
- XXII 2.00
- MACD
- SVRE 0.00
- XXII 0.36
- Stochastic Oscillator
- SVRE 15.23
- XXII 3.90
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The Company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road, and pedestrians.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.